Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Sep 13;11(9):e0161983.
doi: 10.1371/journal.pone.0161983. eCollection 2016.

The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis

Affiliations
Meta-Analysis

The Clinical Usefulness of Tuberculin Skin Test versus Interferon-Gamma Release Assays for Diagnosis of Latent Tuberculosis in HIV Patients: A Meta-Analysis

Erfan Ayubi et al. PLoS One. .

Erratum in

Abstract

Background: Accurate diagnosis of latent tuberculosis infection (LTBI) is becoming increasingly concerning due to the increasing the HIV epidemic, which have increased the risk for reactivation to active tuberculosis (TB) infection. LTBI is diagnosed by tuberculin skin test (TST) and interferon-gamma release assays (IGRAs).

Objectives: The aim of the present study was to conduct a meta-analysis of published papers on the agreement (kappa) between TST and QuantiFERON-TB Gold In-Tube (QFT-GIT) tests for diagnosis of LTBI in HIV patient.

Methods: Electronic databases including PubMed/Medline, Elsevier/Scopus and Embase/Ovid were reviewed up Jan. 2016. We performed a random effect model meta-analysis for estimation of pooled Kappa between the two methods of diagnosis. Meta regression was used for assessing potential heterogeneity and Egger's test was used for assessing small study effect and publication bias.

Results: The initial search strategy produced 6744 records. Of them, 23 cross-sectional studies met the inclusion criteria and 20 studies entered in meta-analysis. The pooled kappa was and prevalence-adjusted and bias-adjusted kappa (PABAK) were 0.37 (95% CI: 0.28, 0.46) and 0.59 (0.49, 0.69). The discordance of TST-/QFT-GIT+ was more than TST+/QFT-GIT-. Kappa estimate between two tests was linearly associated with age and prevalence index and inversely associated with bias index.

Conclusion: Fair agreement between TST and QFT-GIT makes it difficult to know whether TST is as useful as the QFT-GIT in HIV-infected patients. The higher discordance of TST-/QFT-GIT+ in compared to TST+/QFT-GIT- can induce the higher sensitivity of QFT-GIT for diagnosis LTBI in HIV patients. Disagreement between two tests can be influenced by error in measurements and prevalence of HIV.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The flow chart of retrieved studies in meta-analysis.
Fig 2
Fig 2. Funnel plot, using data from the 20 included studies in meta-analysis, with kappa displayed on the horizontal axis and S.E. (kappa) on the vertical axis; symmetrical plot shows the absence of publication bias.
Fig 3
Fig 3. The overall Kappa coefficient: Squares represent kappa from individual studies with 95% confidence intervals; size of square is proportional to the weight assigned to included studies in the meta-analysis.
The diamond represents the overall results and 95% confidence interval of the random effect of the meta-analysis.
Fig 4
Fig 4. Meta regression plot for effect of explanatory variables on variation of kappa estimate.
(A) Age. (B) Prevalence index. (B) Bias index.
Fig 5
Fig 5. The overall prevalence adjusted bias adjusted kappa coefficient: Squares represent kappa from individual studies with 95% confidence intervals; size of square is proportional to the weight assigned to included studies in the meta-analysis.
The diamond represents the overall results and 95% confidence interval of the random effect of the meta-analysis.

References

    1. World Health Organization, Geneva: Global tuberculosis control: WHO report 2014: World Health Organization; 2014.
    1. World Health Organization, Geneva: Global tuberculosis control: WHO report 2012. 2012.
    1. Taylor Z, Nolan CM, Blumberg HM. Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Recommendations and reports: Morbidity and mortality weekly report Recommendations and reports/Centers for Disease Control. 2005;54(RR-12):1–81. - PubMed
    1. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?[Review Article]. The International Journal of Tuberculosis and Lung Disease. 2006;10(11):1192–204. - PubMed
    1. Lee Y-M, Park K-H, Kim S-M, Park S, Lee S-O, Choi S-H, et al. Risk factors for false-negative results of T-SPOT. TB and tuberculin skin test in extrapulmonary tuberculosis. Infection. 2013;41(6):1089–95. 10.1007/s15010-013-0478-z - DOI - PubMed